日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hospitalizations and re-hospitalizations at the end-of-life among cancer patients; a retrospective register data study

癌症患者临终阶段的住院和再住院情况:一项回顾性登记数据研究

Singh, J; Grov, E K; Turzer, M; Stensvold, A

Anticancer therapy at end-of-life: A retrospective cohort study

生命末期抗癌治疗:一项回顾性队列研究

Singh, Johnny; Stensvold, Andreas; Turzer, Martin; Grov, Ellen Karine

Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy

监测接受免疫检查点抑制剂/化疗联合治疗的晚期小细胞肺癌患者的血液免疫细胞

Dagmar Riemann ,Steffi Turzer ,Georgi Ganchev ,Wolfgang Schütte ,Barbara Seliger ,Miriam Möller

Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy

血液免疫细胞作为接受联合免疫/化疗的晚期非小细胞肺癌长期生存患者的生物标志物

Möller, Miriam; Schütte, Wolfgang; Turzer, Steffi; Seliger, Barbara; Riemann, Dagmar

Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint Blockade

接受免疫检查点阻断治疗的肺癌患者的血液免疫细胞生物标志物

Möller, Miriam; Turzer, Steffi; Schütte, Wolfgang; Seliger, Barbara; Riemann, Dagmar

High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy

单核细胞和血液树突状细胞的高 PD-L1/CD274 表达是接受 PD1 抑制剂治疗的肺癌患者的危险因素

Dagmar Riemann, Wolfgang Schütte, Steffi Turzer, Barbara Seliger, Miriam Möller

Blood immune cell biomarkers in lung cancer

肺癌血液免疫细胞生物标志物

Riemann, D; Cwikowski, M; Turzer, S; Giese, T; Grallert, M; Schütte, W; Seliger, B